inscripta.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $459.69MM
Inscripta, founded in 2015, a biomanufacturing company that specializes in genome engineering, and the developer of a gene-editing technology. The proprietary gene-editing technology offers trackable editing of single cells at scale, aiming to “bring affordable and sustainable synthetic biology to market”.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/05/2021 | Series E | $150MM | $xx.xx | $1.32B | Fidelity, T. Rowe Price | |
Price per Share
$xx.xx
Shares Outstanding
16,987,539
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Fidelity, T. Rowe Price
|
||||||
11/13/2020 | Series D | $175MM | $xx.xx | $594.94MM | Venrock, Foresite, Paladin Capital, Mrieux Dveloppement, NanoDimension, MLS Capital, JS Capital Management LLC, Oak HC/FT | |
Price per Share
$xx.xx
Shares Outstanding
38,293,202
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Venrock, Foresite, Paladin Capital, Mrieux Dveloppement, NanoDimension, MLS Capital, JS Capital Management LLC, Oak HC/FT
|
||||||
04/19/2019 | Series C-1 | $50MM | $xx.xx | $278.92MM | Venrock, Foresite, Mrieux Dveloppement, Paladin Capital, MLS Capital, NanoDimension | |
Price per Share
$xx.xx
Shares Outstanding
15,197,562
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Venrock, Foresite, Mrieux Dveloppement, Paladin Capital, MLS Capital, NanoDimension
|
||||||
02/28/2018 | Series C | $55.5MM | $xx.xx | $182.26MM | Mrieux Dveloppement, Paladin Capital | |
Price per Share
$xx.xx
Shares Outstanding
19,204,143
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Mrieux Dveloppement, Paladin Capital
|
||||||
02/28/2017 | Series B | $23.15MM | $xx.xx | $48.64MM | Venrock, Foresite Capital, Paladin Capital, NanoDimension, Spruce/?MLS | |
Price per Share
$xx.xx
Shares Outstanding
19,784,629
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Venrock, Foresite Capital, Paladin Capital, NanoDimension, Spruce/?MLS
|
||||||
05/30/2016 | Series A | $6.04MM | $xx.xx | $13.41MM | NanoDimension, Spruce/MLS | |
Price per Share
$xx.xx
Shares Outstanding
5,157,970
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
NanoDimension, Spruce/MLS
|